SBIR/STTR Research Award

Vaginal Gel to Enhance Lubrication & Sperm Function

Award identifier 0be4962d15a685e2ebe4df36c21c39a5cf77ae6c03f82594403c11ef55eee642Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$98,888

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ING FERTILITY, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): ING Fertility, LLC ("ING") is a woman-owned company that markets and brands products targeted to the demographic sector of couples trying to conceive children. This Phase I SBIR proposal aims to validate proof of concept for a vaginal gel, "Pro~Cept, designed to provide sperm-safe personal lubrication and an optimal environment for post-ejaculatory sperm function, to promote cervical mucus penetration. Pro~Cept is designed for use by the 11 million US couples who are trying to conceive at any given time (6 million infertile and 5 million fertile couples), and encompasses an estimated US market potential of over $300M per year. Pro~Cept's proprietary plant polysaccharide ingredient has been shown in preliminary studies to mitigate oxidative damage of sperm which can lead to their decreased function including ability to fertilize an oocyte. Phase I funding is essential to prove safety and efficacy of Pro~Cept prior to performance of clinical studies required for future commercialization. Successful completion of this project will allow ING to move directly into clinical studies in Phase II to evaluate Pro~Cept's efficacy in promoting sperm function and cervical mucus penetration in vivo. To achieve this goal, ING proposes the following. HYPOTHESIS: A vaginal gel product containing a plant-derived polysaccharide to optimize sperm function can be applied prior to coitus to provide sperm safe (non-toxic) lubrication and create an optimal environment for post-ejaculatory sperm function. OBJECTIVES: To extend testing and development of a vaginal gel product, "Pro~Cepf ', for use by both fertile and infertile couples who are trying to conceive. Phase I studies are proposed by the company to evaluate the following aims: 1. The efficacy of Pro~Cept to protect and/or enhance the function of ejaculated sperm as assessed by in vitro assays of motility, cervical mucus penetration, oxidative stress, and chromatin stability over time; and 2. The reproductive safety of Pro~Cept in studies of sperm transport and in vivo fertilization rates in rabbits. > No product is currently available for trying to conceive couples that can provide sperm safe personal lubrication and an optimal environment for post-ejaculatory sperm function, With Pro~Cept, ING has the opportunity to commercialize a "first of kind" personal, home-use product targeted to a highly motivated end user group with a large unmet and well-perceived need.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.